LGND vs MSFT: Which Stock is Better?
Side-by-side comparison of Ligand Pharmaceuticals Inc and Microsoft Corp in 2026
LGND
Ligand Pharmaceuticals Inc
$231.82
MSFT
Microsoft Corp
$422.50
Key Metrics Comparison
| Metric | LGND | MSFT | Winner |
|---|---|---|---|
| Market Cap | $4.62B | N/A | LGND |
| P/E Ratio | 37.82 | 26.46 | MSFT |
| EPS (TTM) | $6.13 | $15.98 | MSFT |
| Revenue Growth | 0.4% | 0.2% | LGND |
| Gross Margin | 64.3% | 68.6% | MSFT |
Analyze LGND
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is LGND or MSFT a better investment?
Comparing LGND and MSFT: Ligand Pharmaceuticals Inc has a market cap of $4.62B while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between LGND and MSFT?
LGND (Ligand Pharmaceuticals Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: LGND or MSFT?
Based on P/E ratios, MSFT trades at a lower multiple (26.5x vs 37.8x).
Which is growing faster: LGND or MSFT?
LGND has higher revenue growth at 0.4% vs 0.2% for MSFT.
Which company is more profitable: LGND or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.6% compared to 64.3% for LGND.
Which is the larger company: LGND or MSFT?
Ligand Pharmaceuticals Inc (LGND) is larger with a market cap of $4.62B compared to N/A for MSFT.
Should I buy LGND or MSFT in 2026?
Both LGND and MSFT have investment merit. LGND trades at $231.82 while MSFT trades at $422.50. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between LGND and MSFT stock?
Key differences: Market Cap ($4.62B vs N/A), P/E Ratio (37.8x vs 26.5x), Revenue Growth (0.4% vs 0.2%), Gross Margin (64.3% vs 68.6%).